Abstract: Macroautophagy was originally discovered as a nutrient salvage pathway during starvation. By now it has not only become clear that degradation of cytoplasmic constituents via transport by autophagosomes to lysosomes can be used for innate and adaptive immunity, but that the core machinery assists antigen presentation to the immune system by a variety of vesicular transport pathways. All of these rely on the presentation of small protein waste fragments, which are generated by a variety of catabolic pathways, including macroautophagy, on major histocompatibility complex (MHC) molecules. In this review, we will point out how classical macroautophagy, as well as phagocytosis and exocytosis, which both benefit from the core autophagic machinery, assist in antigen presentation on MHC class I and II molecules to CD8+ and CD4+ T cells, respectively. Finally to high-light that macroautophagy is always intimately interconnected with cell death in addition to the various supported vesicular transport function, its role in lymphocyte, especially T cell, development and function will be discussed. From this body of work a picture is emerging that the core machinery of macroautophagy can be used for a variety of vesicular transport pathways and to modulate cell survival, besides its classical role in delivering intracellular material for lysosomal degradation. 
Introduction
The adaptive immune system hinges on the orchestration by CD4 + helper T cells and cytotoxic CD8 + T cells as main effectors of cell-mediated immunity. These lymphocyte populations do not recognize antigen directly, but their T cell receptors detect antigen fragments on major histocompatibility (MHC) class I molecules for CD8 + T cells and MHC class II for CD4 + T cells.
These fragments, peptides of eight or nine amino acids in length for MHC class I and longer, often N-and C-terminal extensions of a nonameric core sequence for MHC class II, are generated and loaded onto MHC class I and II molecues in different cellular compartments [1, 2] .
MHC class I ligands are in their majority generated by the proteasome, a multicatalytic protease in cytosol and nucleus. In contrast, peptides for MHC class II loading are primarily produced in lysosomes. Loading of MHC class I and II molecules occurs primarily in the endoplasmic reticulum (ER) and late endosomes, respectively. Both molecules are co-translationally inserted into the ER. MHC class I ligands of proteasome origin get transported into the ER by the transporter associated with antigen processing (TAP) and loaded onto MHC class I molecules in the MHC class I loading complex, containing aminopeptidases, chaperones and protein disulfide isomerases. Once a high affinity peptide is loaded into the peptide binding groove of MHC class I, the complex is transported to the cell surface for CD8 + T cell recognition. Peptide binding to MHC class II molecules in the ER is prevented by the chaperone invariant chain (Ii), which blocks the peptide binding groove and contains in its cytosolic domain motifs that will facilitate the transport to late endosomes, either via the cell membrane or directly. [3] . During cross-presentation, antigen is thought to escape from early endosomes or even after endosome fusion with the ER into the cytosol for proteasomal degradation. Vice versa, intracellular antigen fragments can be found on MHC class II molecules and autophagy contributes to this processing as will be discussed in the next chapter.
Delivery of intracellular antigens for MHC class II presentation via autophagy
Evidence of intracellular antigen processing onto MHC class II molecules originally came from peptide elution studies, which were aimed at characterizing the ligand repertoire that is presented to CD4 + T cells. These studies revealed that up to one third of eluted MHC class II ligands originate from cytosolic and nuclear source proteins [4] [5] [6] . MHC class II presentation of these cytosolic and nuclear antigens can be enhanced by starvation, which up-regulates macroautophagy [4] . Among these peptides, the essential autophagy proteins LC3 and GABARAP were found [4, 7] . These are mammalian orthologs of the ubiquitin-like autophagy related gene (Atg) 8 protein that get coupled to the membranes of autophagosomes, the characteristic double-membrane vesicles of macroautophagy, during its formation around its substrates [8] . This conjugation is mediated by the E3-like ligase composed of Atg5, Atg16L and all Atgs are recycled from the outer membrane upon autophagosome completion ( Figure 1 ).
Therefore, the Atg8 homologues LC3 and GABARAP are in part degraded with the autophagosome cargo in late endosomes or autolysosomes by lysosomal hydrolases and can reach MHC class II loading. Accordingly, LC3 can be used to deliver antigens to autophagosomes, which frequently fuse with MIICs [9] . This targeting enhances antigen presentation on MHC class II molecules up to 20fold [9, 10] . A physiological condition, under which this self-antigen processing by macroautophagy seems to play a role is thymic selection.
Both positive and negative T cell selection was affected in Atg5 negative thymi [11] . During these processes intracellular self-proteins are thought to be presented on MHC class II molecules of thymic epithelial cells (TECs) to ensure low affinity interactions of the selected T cell receptors during positive selection, and eliminating high-affinity T cell receptors against selfproteins during negative selection [12] . Macroautophagy deficiency changes the repertoire of MHC class II presented ligands so that some T cell receptor specificities no longer efficiently survive positive selection, and an autoreactive T cell repertoire emerges from faulty negative selection. Accordingly, autophagosomes fuse frequently with MIICs in TECs [13] , and macroautophagy substrates, like mitochondrial proteins and LC3 fusion proteins can induce negative selection [14] . Thus, self-antigens gain access to MHC class II presentation in part via macroautophagy, and this process assists thymic T cell selection.
Following these indications that macroautophagy might contribute to intracellular selfantigen loading onto MHC class II molecules, several viral and bacterial antigens have been investigated for their processing via macroautophagy for CD4 + T cell stimulation. Among these, the nuclear antigen 1 of the Epstein Barr virus (EBNA1) was found to be intracellularly processed for MHC class II presentation [15] . This processing involved lysosomal degradation, and upon inhibition of lysosome acidification EBNA1 accumulated in double membrane vesicles Romao, Gannage and Münz 6 [16] . Moreover, siRNA mediated silencing of Atg12 compromised EBNA1 specific CD4 + T cell recognition of EBV infected B cells [16] . EBNA1 processing for MHC class II presentation was enhanced after blocking its access to the nucleus by mutating the nuclear localization domain of EBNA1 [17] . This also broadened macroautophagic antigen processing to additional EBNA1
epitopes. Therefore, physiological levels of EBNA1 are processed for MHC class II presentation by macroautophagy.
Apart from this viral protein, bacterial antigens are processed via this pathway. The transposon-derived neomycin phosphotransferase II (NeoR) gets intracellularly processed by lysosomal hydrolysis for MHC class II presentation [18] . This processing is sensitive to pharmacological macroautophagy inhibitors, and influenza hemagglutinin epitope fusion to NeoR augments MHC class II presentation of this epitope [10, 18] . Interestingly, forced nuclear localization of NeoR does not compromise macroautophagy mediated processing of this antigen for MHC class II presentation [19] . Therefore, nuclear localization might not protect from macroautophagy for all antigens in all cellular backgrounds similarly well. Nevertheless, cytosolic localization probably favors access of antigen to autophagosomes and processing for MHC class II presentation via this pathway. Accordingly, proteins that are injected into the cytosol by bacteria have been described to fall prey to macroautophagy, followed by MHC class II presentation. Along these lines mycobacterial Ag85B is better presented after macroautophagy stimulation by MHC class II molecules of DCs, which then upon adoptive transfer prime more efficiently CD4 + T cell responses in vivo [20] . Furthermore, antigens fused to YopE, a Yersinia protein that is injected into the cytosol, are intracellularly processed for MHC class II presentation by a mechanism involving lysosomes and macroautophagy [21] . Thus, bacterial antigens, especially those that escape endosomes, can be processed via macroautophagy for MHC class II presentation.
In addition to this role for macroautophagy in intracellular antigen delivery to MIICs, another autophagic pathway has been implicated in autoantigen delivery for MHC class II Romao, Gannage and Münz 7 presentation. This pathway is called chaperone-mediated autophagy (CMA) and transports cytosolic proteins for degradation into lysosomes via a translocon in the lysosomal membrane [22] . While this pathway might be avoided by pathogens due to its signal peptide dependency, whose motifs could be easily mutated in pathogen-derived proteins, it has been implicated in antigen processing of autoantigens onto MHC class II molecules. Glutamate decarboxylase 65
(GAD65) and the mutant human immunoglobulin  light chain SMA, autoantigens in diabetes mellitus and autoimmune hepatitis, respectively, were found to be better intracellularly processed for MHC class II presentation after overexpression of Lamp2a, a lysosomal transmembrane protein that is an integral part of the CMA translocon [23] . Thus, autoantigens that carry a signal peptide for CMA can be intracellularly processed for MHC class II presentation by pathways independent of macroautophagy.
Modification of extracellular antigen processing for MHC class II presentation by autophagy
Consistent with this contribution of macroautophagy to antigen processing for MHC class II antigen presentation, diminished herpes simplex virus (HSV) specific CD4 + T cell responses and compromised immune control of HSV was observed in mice with Atg5 deficient CD11c + cells, presumably DCs [24] . However, in this study it was also noted that macroautophagy deficient
DCs presented different formulations of extracellular antigen less efficiently to CD4 + T cells, and that the acquisition of active lysosomal hydrolases by endosomes was delayed in the absence of macroautophagy. These findings were consistent with an earlier report, suggesting that the core machinery of macroautophagy, which executes the Atg8 lipidation, was involved in phagosome maturation [25] . This study suggested that cargo that engages pathogen-associated molecular pattern (PAMP) receptors, like TLR2, recruits the Atg8 ortholog LC3 to the phagosomal membrane that surrounds it after uptake (Figure 1 ). Furthermore, this LC3 associated phagocytosis (LAP) was suggested to accelerate fusion with lysosomes and degradation of the shown to stimulate LAP [27, 28] . Dectin-1 mediated antigen uptake was, moreover, shown to enhance MHC class II presentation via LAP [28] . However, all these studies suggested that LAP accelerates phagocytosed cargo degradation, yet MHC class II antigen presentation had previously been shown to benefit from attenuated endosomal degradation [29, 30] . Therefore, future studies will have to define if the LAP vesicles that lead to MHC class II antigen presentation also show accelerated maturation, and, more generally, by which molecular mechanisms LC3 conjugation to the phagosomal membrane modulates the fate of LAP vesicles.
In addition to the regulation of phagocytosis by the molecular core machinery of macroautophagy, lysosomal hydrolase delivery by autophagosomes has been implicated in autoantigen processing for MHC class II presentation (Figure 1 ). Citrullinated peptides are generated by peptidylarginine deiminases (PADs) and recognized by the adaptive immune system during rheumatoid arthritis [31] . MHC class II presentation of citrullinated epitopes of the model antigen hen egg lysozyme has been described to require macroautophagy [32] . PAD2 and 4, which are expressed in the immune system, seemed to be delivered by autophagsomes to endosomes for the generation of the citrullinated T cell epitopes. Therefore, macroautophagy can also assist extracellular antigen processing by modulating the content of endosomes and lysosomal hydrolysis.
Contribution of autophagy to MHC class I antigen presentation
While LAP and intracellular antigen processing by macroautophagy seem to modulate MHC class II presentation for a subset of antigens, the role of macroautophagy for MHC class I presentation is much less understood. Initially, it seemed like antigen targeting to autophagosomes [9] and compromising macroautophagy in DCs or TECs in vivo [11, 24] (Figure 2 ).
Similarly, TAP independent antigen processing of the human cytomegalovirus (HCMV) protein pUL138 for MHC class I presentation was found to require macroautophagy [34] . While, however, HSV gB processing was still proteasome dependent, HCMV pUL138 degradation was proteasome independent, suggesting that maybe an endosomal MHC class I loading compartment requires macroautophagy for its formation, and can receive input from lysosomal or proteasomal antigen processing. Supporting this notion is the recent finding that crosspresentation of the F protein of the respiratory syncytial virus (RSV) also requires macroautophagy, but is independent of TAP and proceeds via lysosomal degradation [35] .
Indeed, MHC class I molecules can reach endosomal loading also in TAP deficient cells at low temperatures, and then cross-presentation of exogenous antigen becomes TAP independent [36] . In addition to endosomal loading of viral antigens onto MHC class I molecules, a recent study argues in favor of a contribution of macroautophagy to endosomal processing of MHC class I epitopes in the case of chlamydia infection [37] . 
Packaging of antigens via autophagy for antigen presentation
In addition to delivery of cytoplasmic constituents for lysosomal degradation, macroautophagy has also been implicated in signal peptide independent secretion. Exocytosis via macroautophagy was first reported in yeast [38, 39] . In these studies acyl coenzyme A-binding protein (ACBP) was shown to exit cells in a macroautophagy dependent manner, requiring the fusion machinery for the plasma membrane, but not the lysosomal vacuole. Similarly, it has been suggested that IL-1, a cytokine that is also secreted by a non-conventional pathway, is released by macroautophagy mediated exocytosis [40] . Finally, amorphous extracellular deposits in age related macular degeneration, so called drusen, also contains autophagosome markers [41] . The releasing retinal pigment epithelium displays increased macroautophagy, decreased lysosomal activity and elevated exocytosis, which could indicate augmented exocytosis via macroautophagy. Such exocytosis could be beneficial for antigen crosspresentation by packaging cytoplasmic material optimally for uptake by bystander antigen presenting cells (Figure 2 ). Along these lines it has been found that influenza A virus and tumor antigens were only efficiently cross-presented onto MHC class I molecules, when the antigen donor cells were macroautophagy competent [42, 43] . Influenza A virus blocks autophagosome maturation and the accumulating autophagosomes contain viral antigens [44] . This arrest could promote exocytosis. Similarly, autophagosomes from tumor cells lines contain tumor antigens [43] , and the inner autophagosomal membrane plus this tumor antigen cargo could be released Romao, Gannage and Münz 11 for cross-presentation via exocytosis (Figure 2 ). Therefore, macroautophagy might assist the release of antigens for cross-presentation on MHC class I molecules to T cells.
Regulation of lymphocyte function via autophagy
In addition to influencing T cell education by antigen presentation during positive and negative selection in the thymus, macroautophagy also cell-intrinsically influences lymphocyte differentiation and function. Both immature T and B cells seem to require macroautophagy during their development [45] [46] [47] . Altered B cell differentiation in the absence of macroautophagy does, however, only lead to decreased B1 cell numbers [47] , while overall B cell reconstitution is not significantly changed [45] . Upon further differentiation to plasma cells, however, macroautophagy is required for the maintenance of these antibody production plants [48, 49] .
Atg5 deficient plasma cells were found to suffer from expanded ER and increased unfolded protein response stress, leading to their elevated cell death. In immature T cells, so called thymocytes, macroautophagy seems to protect from toxic reactive oxygen species (ROS) production by decreasing mitochondrial mass [50, 51] . Macroautophagy up-regulation for mitochondrial clearance seems to be achieved through activation of the transient receptor potential vanilloid 1 (TRPV1) via NADPH oxidase produced ROS, which activate adenosine monophosphate-activated protein kinase (AMPK) to inhibit mammalian target of rapamycin (mTOR) to activate macroautophagy [52] . In addition, ROS inhibit Atg8 deconjugation by Atg4 to sustain autophagosomal membrane formation [53] . In contrast to these now even mechanistically well understood effects of macroautophagy loss during adaptive lymphocyte development, it remains less clear to which extent this affects the function of these cells in the periphery. While it was originally reported that T cell proliferation after T cell receptor stimulation is compromised in the absence of macroautophagy [46] , a more recent study suggested that mature T cells were able to expand efficiently with diminished macroautophagy [45] . Therefore, it seems clear that macroautophagy protects from cell death during T and B cell differentiation, but its prosurvival role during adaptive lymphocyte activation seems less essential with the exception of plasma cell differentiation.
While physiological macroautophagy levels protect from cell death in most instances, too dramatic induction of this pathway or overexpression of some Atgs can instead compromise cell survival. Along these lines, macroautophagy seemed to contribute to cell death in Th2 polarized CD4 + T cells, which display higher autophagosome numbers than Th1 polarized CD4 + T cells [54] . Moreover, overexpression of Atg6 sensitizes thymocytes for apoptosis induction [55] .
However, this observation could also be explained by the sequestration of anti-apoptotic Bcl-2 by Atg6. Thus, macroautophagy protects from cell death during development, but can diminish or enhance lymphocyte function after maturation. The characteristics of immune responses with these different requirements for macroautophagy need to be determined in the future to predict the outcome of macroautophagy regulating interventions on protective or pathogenic lymphocytes.
Conclusions and outlook
Recent studies have revealed that the molecular machinery of macroautophagy does not only serve the purpose of transporting cytoplasmic constituents for lysosomal degradation, but also influences vesicular transport pathways in a broader sense. Indeed, in addition to autophagosome generation, macroautophagy seems to modulate endo-and exocytosis.
Moreover, the intimate connections with the cell death machinery, exemplified by the complex formation of Atg6 with Bcl-2, always affects also survival of the macroautophagy regulating cell, in parallel to vesicular transport. Future research will need to characterize how this modular format of the macroautophagy machinery can be specifically recruited to fulfill these different tasks and how one might selectively regulate these different functions of macroautophagy for therapeutic benefit. 
